spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Bio-T-Gel 

 HSMN NewsFeed - 15 Feb 2012
BioSante Pharmaceuticals Announces FDA Approval for Bio-T-Gel™
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Jul 2011
BioSante Pharmaceuticals Announces Management Team Additions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Feb 2011
BioSante Pharmaceuticals Reports Positive LibiGel(R) Safety Data in Phase III Program
Biopharmaceuticals
 HSMN NewsFeed - 9 Feb 2010
BioSante Pharmaceuticals Appoints Jeffrey W. Winkelman, Ph.D., J.D., Vice President, Oncology Programs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jun 2009
BioSante Pharmaceuticals and Cell Genesys Sign Definitive Merger Agreement
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 14 Apr 2009
BioSante Announces Launch of Elestrin in the U.S.
Biopharmaceuticals
 HSMN NewsFeed - 7 Aug 2008
BioSante Pharmaceuticals Announces Reacquisition of Elestrin(TM), FDA Approved for Treatment of Hot Flashes
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 15 Apr 2008
BioSante Pharmaceuticals Appoints Michael C. Snabes, M.D., PhD, Vice President, Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Mar 2008
BioSante Pharmaceuticals Initiates Third LibiGel(R) Phase III Trial in the Treatment of Female Sexual Dysfunction under an SPA
Biopharmaceuticals
 HSMN NewsFeed - 29 Jan 2008
BioSante Pharmaceuticals Announces FDA Special Protocol Assessment (SPA) for LibiGel(R) in FSD
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Jan 2008
BioSante Pharmaceuticals Announces Initiation of LibiGel(R) (Transdermal Testosterone Gel) Phase III Safety Study
Biopharmaceuticals
 HSMN NewsFeed - 11 Sep 2007
BioSante Pharmaceuticals Announces FDA Clarity on Development of LibiGel(R) (Transdermal Testosterone Gel) in the Treatment of Female Sexual Dysfunction
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Sep 2007
BioSante Pharmaceuticals Names Joy A. Thomas Vice President of Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jun 2007
New Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aged 50-59 taking Estrogen Therapy
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 13 Jun 2007
BioSante Pharmaceuticals Announces the Commercial Launch of Elestrin(TM)
Biopharmaceuticals
 HSMN NewsFeed - 12 Jun 2007
BioSante Pharmaceuticals Announces Reinitiation of Product Development With Teva
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 5

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 5 additional stories matching:
Bio-T-Gel
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.